GAMMA-MRI

Innovating with gamma-MRI for precise, early detection in stroke care, leveraging AI for imaging enhancement.

Stroke is the second most common cause of death worldwide, and the extent of ischaemic damage is the determinant factor for treatment. There is a very narrow time window of a few hours for treatment initiation, but point-of-care molecular imaging is lacking. To address this problem, the EU-funded GAMMA-MRI project is proposing the development of a breakthrough imaging technology manipulating gamma rays with MRI, combining the best of these two technologies. This novel device incorporates artificial intelligence and is expected to advance molecular imaging while bringing the personalised early management of stroke a step closer to reality.